000 01531 a2200433 4500
005 20250517051458.0
264 0 _c20160912
008 201609s 0 0 eng d
022 _a1934-8290
024 7 _a10.1002/0471141755.ph0547s70
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFurman, Brian L
245 0 0 _aStreptozotocin-Induced Diabetic Models in Mice and Rats.
_h[electronic resource]
260 _bCurrent protocols in pharmacology
_cSep 2015
300 _a5.47.1-5.47.20 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aDiabetes Mellitus, Experimental
_xpathology
650 0 4 _aDiabetes Mellitus, Type 1
_xchemically induced
650 0 4 _aDiabetes Mellitus, Type 2
_xchemically induced
650 0 4 _aDiet, High-Fat
650 0 4 _aDisease Models, Animal
650 0 4 _aDisease Progression
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aHyperglycemia
_xblood
650 0 4 _aInjections, Intraperitoneal
650 0 4 _aInsulin
_xdeficiency
650 0 4 _aInsulin-Secreting Cells
_xpathology
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aNiacinamide
_xadministration & dosage
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aRats, Wistar
650 0 4 _aStreptozocin
_xadministration & dosage
773 0 _tCurrent protocols in pharmacology
_gvol. 70
_gp. 5.47.1-5.47.20
856 4 0 _uhttps://doi.org/10.1002/0471141755.ph0547s70
_zAvailable from publisher's website
999 _c25224392
_d25224392